Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors

Journal of Pediatric Surgery

Volumn 41, Issue 3, 2006, Pages 560-566

  Tajiri, Tatsuro ^a   Tanaka, Shinji ^a   Higashi, Mayumi ^a   Kinoshita, Yoshiaki ^a   Takahashi, Yukiko ^a   Tatsuta, Kyosuke ^a   Suita, Sachiyo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BIN1; MYCN; Neuroblastoma; Quantitative PCR; Survivin

Indexed keywords

PROTEIN P53; SURVIVIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; HUMAN; INFANT; MALE; NEUROBLASTOMA; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 33644680121     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.11.067     Document Type: Article

References (23)

1. W.M. Crist, and LE. Kun Common solid tumors of childhood N Engl J Med 324 1991 461 471
2. G.M. Brodeur Molecular basis for heterogeneity in human neuroblastoma Eur J Cancer 31 1995 505 510
3. G.M. Brodeur, J.M. Maris, and D.J. Yamashiro Biology and genetics of human neuroblastomas J Pediatr Hematol Oncol 19 1997 93 101
4. G.M. Brodeur, R.C. Seeger, and M. Schwab Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage Science 224 1984 1121 1124
5. W. Lutz, M. Stohr, and J. Schurmann Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells Oncogene 13 1996 803 812
6. S.B. Bordow, M.D. Norris, and P.S. Haber Prognostic significance of MYCN oncogene expression in childhood neuroblastoma J Clin Oncol 16 1998 3286 3294
7. R.C. Seeger, R. Wada, and G.M. Brodeur Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene Prog Clin Biol Res 271 1998 41 49
8. H.N. Caron Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma Med Pediatr Oncol 24 1995 215 221
9. M. Lastowska, S. Cotterill, and A.D.J. Pearson Gain of chromosome arm 17q predicts unfavorable outcome in neuroblastoma patients Eur J Cancer 33 1997 1627 1633
10. D. Plantaz, G. Mohapatra, and K.K. Matthay Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization Am J Pathol 150 1997 81 89
11. C. Adida, P.L. Crotty, and J. McGrath Developmentally regulated expression of the novel cancer anti-apoptosis gene Survivin in human and mouse differentiation Am J Pathol 19 1998 617 623
12. A. Islam, H. Kageyama, and N. Takada High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma Oncogene 19 2000 617 623
13. T. Tajiri, S. Tanaka, and K. Shono Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma Cancer Lett 166 2001 89 94
14. M.D. Hogarty, X. Liu, and P.M. Thompson BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification Med Pediatr Oncol 35 2000 559 562
15. T. Tajiri, S. Tanaka, and S. Suita Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features Clin Cancer Res 9 2003 3345 3355
16. I. Laurendeau, M. Bahuau, and N. Vodovar TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK 4 locus haploinsufficiency Clin Chem 45 1999 982 986
17. H. Kariyazono, K. Ihara, and T. Ohno Rapid detection of 22q11.2 deletion with quantitative real-time PCR Mol Cell Probes 15 2001 71 73
18. G.M. Brodeur, J. Pritchard, and F. Berthold Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 1993 1466 1477
19. H. Shimada, J. Chatten, and W.A. Newton Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas J Natl Cancer Inst 73 1984 405 416
20. T. Kusafuka, M. Fukuzawa, and T. Oue Mutation analysis of p53 gene in childhood malignant solid tumors J Pediatr Surg 32 1997 1175 1180
21. S. Tanaka, T. Tajiri, and S. Suita Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma J Pediatr Surg 39 2004 63 68
22. L.A. Diaz Jr The current clinical value of genomic instability Semin Cancer Biol 15 2005 67 71
23. M. Kaneko, H. Nishihira, and H. Mugishima Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status Med Pediatr Oncol 31 1999 1 7